¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"insulin test"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • oxytocin sensitivity test
    ¿Á½ÃÅä½Å¹Î°¨µµ°Ë»ç
  • test object
    ½ÃÇè´ë»ó, Ç¥½Ä¹°
  • parametric test
    ÁöÇ¥°ËÁ¤
  • passive mobility test
    ¼º´ë°¡µ¿°Ë»ç
  • pastpointing test
    Áö½Ã°Ë»ç
  • patch test
    ºÎÂøÆ÷°Ë»ç, øÆ÷°Ë»ç
  • paternity test
    Ä£ÀÚ°¨Á¤
  • pendular rotation test
    ÈçµéÀÌȸÀü°Ë»ç
  • penile tumescence test
    À½°æÆØÃ¢°Ë»ç
  • percent reactive antibody test
    ¹éºÐÀ²¹ÝÀÀÇ×ü°Ë»ç
  • percutaneous test
    °æÇǰ˻ç
  • performance test
    ¼öÇà°Ë»ç
  • pilot test
    ¿¹ºñ°Ë»ç
  • positioning nystagmus test
    À§Ä¡´«¶³¸²°Ë»ç, µÎÀ§º¯È¯¾ÈÁø°Ë»ç
  • postcoital test
    ¼º±³Èİ˻ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • antiglobulin test
    Çױ۷κҸ°½ÃÇè
  • antiglobulin test, direct
    Á÷Á¢ Çױ۷κи° °Ë»ç
  • antiglobulin test, indirect
    °£Á¢Çױ۷κҸ° °Ë»ç
  • antimicrobial susceptibility test
    Ç×±Õ¹°Áú °¨¼ö¼º(ù÷жڪòõÊïáôàõ)½ÃÇè.
  • antimicrobial susceptibility test
    Ç×±Õ¹°Áú °¨¼ö¼º(ù÷жڪòõÊïáôàõ)½ÃÇè.
  • antimicrobial susceptibility test
    Ç×±ÕÁ¦°¨¼ö¼º½ÃÇè
  • antinuclear antibody test
    Ç×ÇÙ Ç×ü °Ë»ç
  • antitrypsin test
    Çׯ®¸³½Å½ÃÇè.
  • apomorphine test
    ¾ÆÆ÷¸ð¸£ÇɽÃÇè.
  • aptitude test
    Àû¼º½ÃÇè(îêàõãËúÐ).
  • aptitude test
    Àû¼º(îêàõ)°Ë»ç
  • arborization test
    ºÐÁö(ÝÂò«)½ÃÇè
  • arm to tongue time test
    ÆÈÇô¼øÈ¯½Ã°£½ÃÇè
  • arsenic test
    ºñ¼Ò½ÃÇè¹ý.
  • artificial erection test
    Àΰø¹ß±â °Ë»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • coccidioidin test
    Ä۽õð¿ÀÀ̵ò½ÃÇè(¡­ãËúÐ).
  • coccidioidin test
    Ä۽õð¿ÀÀ̵ò½ÃÇè(¡­ãËúÐ).
  • cold caloric test
    Çѳð˻ç
  • cold pressor test
    ÇÑ·©Ç÷¾Ð¹ÝÀÀ°Ë»ç
  • cold water test
    ħ¼ö¹ý(öÙâ©Ûö), ³Ã¼ö½ÃÇè.
  • colloidal gold test
    ±³»ó±Ý°Ë»ç(ÎïßÒÐÝËþÞÛ)
  • colloidal gold test
    ±³»ó¿°È­±Ý½ÃÇè.
  • colo(u)rimetric caries susceptibility test
    ¿ì½Ä°¨¼ö¼º ºñ»ö½ÃÇè(ó»ãÝÊïáô àõÝïßäãËúÐ).
  • colony inhibition test
    Áý¶ôÇü¼º ÀúÁö½ÃÇè, ¼¼Æ÷±ºÇü¼º ÀúÁö½ÃÇè
  • color form sorting test
    »öäÇüÅÂ(ßäóôû¡÷¾)Ã߸®±â °Ë»ç(ËþÞÛ)
  • complement consumption test
    º¸Ã¼¼Òºñ½ÃÇè(¡­á¼Þ¨ãËúÐ).
  • complement consumption test
    º¸Ã¼¼Òºñ½ÃÇè(¡­á¼Þ¨ãËúÐ).
  • complement consumption test
    º¸Ã¼¼Òºñ½ÃÇè(¡­á¼Þ¨ãËúÐ).
  • complement fixation inhibition test
    º¸Ã¼°íÁ¤ÀúÇØ½ÃÇè(ÜÍô÷ͳïÒîÁúªãËúÐ).
  • complement fixation inhibition test
    º¸Ã¼°áÇÕÀúÇØ½ÃÇè(ÜÍô÷Ì¿ùêîÁúªãËúÐ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
DEST Denver Eye Screening Test; dichotic environmental sounds test
DPT Demerol, Phenergan, and Thorazine; dermatopontin; dichotic pitch discrimination test; diphtheria-per...
DST desensitization test; dexamethasone suppression test; dihydrostreptomycin; disproportionate septal t...
DT defibillation threshold; delirium tremens; dental technician; depression of transmission; dietetic [...
EAST elevated-arm stress test; Emory angioplasty vs. surgery trial; external rotation, abduction stress t...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
NIDDM Non Insulin Dependent Diabetes Mellitus
NIDDM Non Insulin dependent diabetics
NIDD Non Insulin-Dependent Diabetic
NSILA Non Suppressible Insulin-Like Activity
NIDDM Non-Insulin Dependent
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • hapten inhibition test
    ÇÕÅÙ ÀúÇØ ½ÃÇè
    Ç×üÀÇ Ç׿ø Ư¼ö °áÇÕ ºÎÀ§¸¦ µ¤´Â ÇÕÅÙÀ» ÀÌ¿ëÇÏ¿© Ç׿ø °áÁ¤±âÀÇ Ç÷ûÇÐÀû Ư¼ºÀ» °Ë»çÇÏ´Â ½ÃÇè.
  • Harris and Ray test
    Ç츮½º-·¹ÀÌ ½ÃÇè
    ¿äÁßÀÇ ºñŸ¹Î C¿¡ ´ëÇÑ ¹Ì·® ÀûÁ¤¹ý.
  • heel to knee to shin test
    Á¾½½°æ ½ÃÇè
  • hemadsorption test
    Ç÷±¸ ÈíÂø ½ÃÇè
    Ç÷±¸ ÀÀÁý¼Ò Á¸Àç ½Ã¿¡ ÀûÇ÷±¸°¡ °¨¿°µÈ Á¶Á÷ÀÇ ¼¼Æ÷¿¡ À¯ÂøµÈ´Ù´Â »ç½ÇÀ» ±âÃÊ·Î ÇÏ¿© Ç÷±¸ ÀÀÁý¼º ¹ÙÀÌ·¯½º¸¦ °ËÃâÇÏ´Â »ýü¿Ü ½ÃÇè¹ýÀÌ´Ù.
  • hemagglutination inhibition test
    ÀûÇ÷±¸ ÀÀÁý ¾ïÁ¦ ½ÃÇè
  • hemaggutination test
    ÀûÇ÷±¸ ÀÀÁý ½ÃÇè
  • hematoporphyrin test
    Ç츶ÅäÆ÷¸£ÇǸ° ½ÃÇè
  • hemosiderin test
    Çì¸ð½Ãµ¥¸° Å×½ºÆ®, Ç÷ö¼Ò ½ÃÇè
  • Henry fructose test
    Ç °ú´ç °Ë»ç
  • Henshaw test
    Çî¼î¿ì ½ÃÇè
    ÁÖ¾îÁø Áúȯ¿¡ ´ëÇÑ Àû´çÇÑ È£¸Þ¿ÀÆÄƼ Ä¡·á ¾àÀÇ ¼±ÅÃÀ» ¿ëÀÌÇÏ°Ô ÇÏ´Â °Ë»ç¹ý .ÀÌ Áúȯ¿¡ ´ëÇÏ¿© È£¸Þ¿ÀÆÄƼÀûÀ¸·Î Áö½ÃµÈ °­È­ Ä¡·á¾à¿¡ ÇǰËÀÚÀÇ Ç÷ûÀ» Á¢Ã˽ÃÄ×À» ¶§ ´«¿¡ º¸ÀÌ´Â ¸é»ó ¹ÝÀÀ´ë°¡ ¹ßÇöµÇ¸é ¾çÈ£ÇÑ °ÍÀÌ´Ù.
  • Herzberg's test
    Ç츣Âê¹ö±× ½ÃÇè
    À§¾× Áß¿¡ À¯¸® ¿°»êÀÌ Á¸ÀçÇϸé Äá°í·¹µå ¿ë¾×ÀÌ Ã»»öÀ» ¶ì´Â ½ÃÇè.
  • Heynsius'test
    ÇÏÀνÿ콺 ½ÃÇè
    Çǰ˾׿¡ ÃæºÐÇÑ ¾çÀÇ ÃÊ»êÀ» °¡ÇÏ¿© »ê¼ºÀ¸·Î ¸¸µç ´ÙÀ½ ¿°È­ ³ªÆ®·ýÀÇ Æ÷È­ ¿ë¾×°ú ÇÔ²² ²úÀδÙ. ¾ËºÎ¹ÎÀÌ Á¸ÀçÇÏ¸é ¸é»ó ħÀüÀÌ »ý±ä´Ù.
  • Hildebrant's test
    Èúµ¥ºê¶õÆ® ½ÃÇè
    ¿äÁß¿¡ ¿ì·Îºô¸°ÀÌ ÀÖÀ¸¸é ÃÊ»ê ¾Æ¿¬°ú ¹«¼ö ¾ËÄÝ È¥ÇÕ¹°ÇÏ¿¡¼­ ³ì»ö Çü±¤À» ³ªÅ¸³»´Â ¹ÝÀÀ.
  • Hindenlang's test
    Èùµ¨¶û ½ÃÇè
    Çǰ˾׿¡ °íüÀÇ ¸ÞŸÆ÷½ºÆ÷¸¯»êÀ» °¡ÇßÀ» ¶§ ¾ËºÎ¹ÎÀÌ Á¸ÀçÇϸé ħÀü¹°ÀÌ »ý±â´Â ½ÃÇè.
  • Hines and Brown test
    ÇÏÀνº ºê¶ó¿î ½ÃÇè
    ¾óÀ½ ¹°¿¡ ÇÑÂÊ ¼ÕÀ» ´ã±×°í Ç÷¾ÐÀÇ ¹ÝÀÀÀ» ÃøÁ¤ÇÑ´Ù °úµµ·Î Ç÷¾ÐÀÌ »ó½ÂÇϸé ÀáÀ缺 °íÇ÷¾Ð »óŸ¦ ¶æÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
vitamin B12 absorption test <investigation> This test measures the amount of vitamin B12 in the urine after ingesting a dose of B12. This test evaluates vitamin B12 absorption. The cells in the stomach produce a substance known as intrinsic factor. This substance combines with B12 to allow absorption in the distal ileum. The patient is given a small dose of radioactive B12 which can then be detected in the patients urine. Pernicious anaemia is the clinical result of B12 deficiency. Conditions that can result in an abnormal Schilling test include: deficiency of intrinsic factor, malabsorption or the development of an antibody to intrinsic factor. The Schilling test can be performed with or without administration of intrinsic factor to determine what the underlying cause for pernicious anaemia. Laxative use, renal insufficiency and hypothyroidism can all interfere with the results of this test.
(27 Sep 1997)
vitamin C test A tourniquet test used to determine presence of vitamin C deficiency or thrombocytopenia; a circle 2.5 cm in diameter, the upper edge of which is 4 cm below the crease of the elbow, is drawn on the inner aspect of the forearm, pressure midway between the systolic and diastolic blood pressure is applied above the elbow for 15 minutes, and a count of petechiae within the circle is made: 10, normal; 10 to 20, marginal zone; over 20, abnormal.
See: Rumpel-Leede test.
Synonym: capillary resistance test, vitamin C test.
(05 Mar 2000)
glucose oxidase paper strip test <chemical pathology> A qualitative test for glucose in the urine, in which glucose is oxidised to gluconic acid by glucose oxidase; a specific test, unless ascorbic acid is present.
(05 Mar 2000)
glucose tolerance test <chemical pathology, investigation> A special test where the blood glucose is measure in intervals after a glucose-rich meal is taken, a test used for diagnosing diabetes.
(27 Sep 1997)
VMA test A test for catecholamine-secreting tumours (pheochromocytoma and neuroblastoma) performed on a 24-hr urine specimen; it is based on the fact that vanillylmandelic acid is the major urinary metabolite of norepinephrine and epinephrine.
Synonym: 3-methoxy-4-hydroxymandelic acid test, VMA test.
(05 Mar 2000)
Volhard's test A test for renal function: the patient drinks 1500 ml of water on an empty stomach; if the patient was not dehydrated beforehand and the kidneys are normal, this fluid will be excreted by the end of 4 hr, with specific gravity of the urine being from 1.001 to 1.004.
(05 Mar 2000)
Vollmer test A tuberculin patch test.
(05 Mar 2000)
resorcinol test A test for fructosuria; fresh urine treated with resorcinol in acid gives a red precipitate in the presence of fructose; the precipitate should form a red solution in ethanol.
Synonym: Selivanoff's test.
(05 Mar 2000)
Meinicke test The first successful application (1917-1918) of immune precipitation to diagnosis of syphilis, now obsolete.
(05 Mar 2000)
glycosylated haemoglobin test <investigation> A blood test that measures a person's average blood glucose (sugar) level for the 2- to 3-month period before the test. See: haemoglobin A1C.
(09 Oct 1997)
Gmelin's test A test for bile in the urine or other body fluid; nitric acid, with a little nitrous acid, is cautiously added to a few milliliters of the material to be tested; if bile (bilirubin) is present, it is oxidised to varying degrees, thereby resulting in disklike zones that are (from the interface outward) yellow, red, violet, blue, and green; development of green and violet layers is essential to the validity of the test.
Synonym: Rosenbach-Gmelin test.
(05 Mar 2000)
pentagastrin test An alternative to histamine for stimulation of acid secretion in gastric analysis.
(05 Mar 2000)
Gofman test A test for various serum lipoproteins that contain cholesterol, as an index of the tendency to the development of atheromatous lesions and arteriosclerosis; the test is based on the differential flotation of molecules of various sizes when the serum is treated in an ultracentrifuge.
(05 Mar 2000)
Meltzer-Lyon test A test used in diagnosis of gallbladder conditions: 25 ml of a 25% solution of magnesium sulfate are delivered into the region of the sphincter of Oddi through a duodenal tube, causing contraction of the gallbladder, relaxation of the sphincter, and the expulsion of bile from the common duct and gallbladder; bile from the common duct is relatively pale and is expelled first, that from the gallbladder follows; samples aspirated from the tube are examined for pus cells, pigment granules, epithelial cells, cholesterol, etc.
(05 Mar 2000)
Goldscheider's test Determination of the temperature sense by touching the skin with a sharp-pointed metallic rod, heated to varying degrees.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
ÅëÇÕ°Ë»ö ¿Ï·á